A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus

A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus

Bibliographic Details
Main Authors: Thompson, Melanie, Saag, Michael, DeJesus, Edwin, Gathe, Joseph, Lalezari, Jay, Landay, Alan L., Cade, Jerry, Enejosa, Jeffrey, Lefebvre, Eric, Feinberg, Judith
Format: Online
Language:English
Published: Lippincott Williams & Wilkins 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794136/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794136/

Similar Items